Literature DB >> 21732059

Suppression of lung cancer metastasis-related protein 1 (LCMR1) inhibits the growth of colorectal cancer cells.

E Ji-Fu1, Jun-Jie Xing, Li-Qiang Hao, Chuan-Gang Fu.   

Abstract

Lung cancer metastasis-related protein 1 (LCMR1) is a critical subunit of the mediator complex, and plays an important role in the elaborate regulation of gene transcription. However, the functional role of LCMR1 in colorectal carcinoma (CRC) has not been clarified. In this study, LCMR1 expression in CRC specimens was quantified by using the quantitative reverse transcription polymerase chain reaction method. The effect of downregulation of LCMR1 by lentivirus-mediated small hairpin RNA (shRNA) on CRC cell proliferation and tumorigenesis was explored. There was a higher expression of LCMR1 in CRC tissue in comparison with adjacent normal colon tissue (P < 0.05). LCMR1 gene was effectively knocked down in human CRC RKO and DLD-1 cells that infected with lentivirus delivering shRNA against LCMR1, which resulted in inhibition of cell proliferation and augmentation of G0/G1 phase proportion. Moreover, the tumorigenicity of RKO cells was also dramatically inhibited after LCMR1 was knocked down. In conclusion, our results suggest that LCMR1 promotes CRC cell growth, and lentivirus-mediated silencing of LCMR1 may contribute to the gene therapy for CRC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21732059     DOI: 10.1007/s11033-011-1142-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  30 in total

1.  Enhanced proliferation of cultured human vascular smooth muscle cells linked to increased function of RNA-binding protein HuR.

Authors:  Rudolf Pullmann; Magdalena Juhaszova; Isabel López de Silanes; Tomoko Kawai; Krystyna Mazan-Mamczarz; Marc K Halushka; Myriam Gorospe
Journal:  J Biol Chem       Date:  2005-04-11       Impact factor: 5.157

Review 2.  siRNA and miRNA for the treatment of cancer.

Authors:  R Jankovic; S Radulovic; M Brankovic-Magic
Journal:  J BUON       Date:  2009-09       Impact factor: 2.533

3.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

Review 4.  Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector.

Authors:  Peter Manilla; Tessio Rebello; Cathleen Afable; Xiaobin Lu; Vladimir Slepushkin; Laurent M Humeau; Kathy Schonely; Yajin Ni; Gwendolyn K Binder; Bruce L Levine; Rob-Roy MacGregor; Carl H June; Boro Dropulic
Journal:  Hum Gene Ther       Date:  2005-01       Impact factor: 5.695

5.  The structural and functional role of Med5 in the yeast Mediator tail module.

Authors:  Jenny Béve; Guo-Zhen Hu; Lawrence C Myers; Darius Balciunas; Olivera Werngren; Kjell Hultenby; Rolf Wibom; Hans Ronne; Claes M Gustafsson
Journal:  J Biol Chem       Date:  2005-10-17       Impact factor: 5.157

6.  Importin 7 may be dispensable for human immunodeficiency virus type 1 and simian immunodeficiency virus infection of primary macrophages.

Authors:  Steven P Zielske; Mario Stevenson
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  RNAi-mediated silencing of ezrin gene reverses malignant behavior of human gastric cancer cell line SGC-7901.

Authors:  Hong Jian Wang; Jin Shui Zhu; Qiang Zhang; Hua Guo; Yun Hai Dai; Xiao Peng Xiong
Journal:  J Dig Dis       Date:  2009-11       Impact factor: 2.325

8.  The ROX3 gene encodes an essential nuclear protein involved in CYC7 gene expression in Saccharomyces cerevisiae.

Authors:  L S Rosenblum-Vos; L Rhodes; C C Evangelista; K A Boayke; R S Zitomer
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

Review 9.  Does RNA interference provide new hope for control of chronic hepatitis B infection?

Authors:  Rachel Wilson; Damian Purcell; Hans J Netter; Peter A Revill
Journal:  Antivir Ther       Date:  2009

Review 10.  The potential of RNA interference-based therapies for viral infections.

Authors:  Diana D Huang
Journal:  Curr HIV/AIDS Rep       Date:  2008-02       Impact factor: 5.071

View more
  5 in total

1.  The SP1-Induced Long Noncoding RNA, LINC00339, Promotes Tumorigenesis in Colorectal Cancer via the miR-378a-3p/MED19 Axis.

Authors:  Hua Ye; Wende Li; Kefeng Wu; Yi Liu; Yingnian Lv; Yuzhen Zhu; Hui Luo; Liao Cui
Journal:  Onco Targets Ther       Date:  2020-11-16       Impact factor: 4.147

2.  A large-scale RNAi screen identifies LCMR1 as a critical regulator of Tspan8-mediated melanoma invasion.

Authors:  G Agaësse; L Barbollat-Boutrand; E Sulpice; R Bhajun; M El Kharbili; O Berthier-Vergnes; F Degoul; A de la Fouchardière; E Berger; T Voeltzel; J Lamartine; X Gidrol; I Masse
Journal:  Oncogene       Date:  2016-07-04       Impact factor: 9.867

3.  Prognostic significance and molecular mechanism of ATP-binding cassette subfamily C member 4 in resistance to neoadjuvant radiotherapy of locally advanced rectal carcinoma.

Authors:  Zhiqi Yu; Chang Zhang; Rui Chai; Yan Du; Xianhua Gao; Junjie Xing; Enda Yu; Wei Zhang; Xiaoqing Zhang; Guangwen Cao; Chuangang Fu
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

4.  Drosophila melanogaster Hox transcription factors access the RNA polymerase II machinery through direct homeodomain binding to a conserved motif of mediator subunit Med19.

Authors:  Muriel Boube; Bruno Hudry; Clément Immarigeon; Yannick Carrier; Sandra Bernat-Fabre; Samir Merabet; Yacine Graba; Henri-Marc Bourbon; David L Cribbs
Journal:  PLoS Genet       Date:  2014-05-01       Impact factor: 5.917

5.  Inhibition of LCMR1 and ATG12 by demethylation-activated miR-570-3p is involved in the anti-metastasis effects of metformin on human osteosarcoma.

Authors:  Xing Bao; Libo Zhao; Hanfeng Guan; Feng Li
Journal:  Cell Death Dis       Date:  2018-05-23       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.